Healthcare provider profile · identity verified

Sejal Thakor, MD

Family Practice · RAYNHAM, MA · NPI 1912136227

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	717	220
Amlodipine Besylate	Amlodipine Besylate	641	199
Losartan Potassium	Losartan Potassium	333	98
Potassium Chloride	Potassium Chloride	208	69
Furosemide	Furosemide	186	65
Hydrochlorothiazide	Hydrochlorothiazide	177	61
Carvedilol	Carvedilol	169	55
Levothyroxine Sodium	Levothyroxine Sodium	166	49
Gabapentin	Gabapentin	163	51
Glipizide Er	Glipizide	156	44
Rosuvastatin Calcium	Rosuvastatin Calcium	155	53
Omeprazole	Omeprazole	151	52
Ezetimibe	Ezetimibe	148	50
Metoprolol Succinate	Metoprolol Succinate	145	47
Metformin Hcl	Metformin Hcl	142	50
Metoprolol Tartrate	Metoprolol Tartrate	132	41
Pantoprazole Sodium	Pantoprazole Sodium	125	50
Allopurinol	Allopurinol	118	35
Albuterol Sulfate Hfa	Albuterol Sulfate	116	51
Meloxicam	Meloxicam	109	40
Alendronate Sodium	Alendronate Sodium	105	31
Famotidine	Famotidine	104	27
Lisinopril	Lisinopril	104	34
Hydralazine Hcl	Hydralazine Hcl	102	35
Metformin Hcl Er	Metformin Hcl	102	27
Farxiga	Dapagliflozin Propanediol	100	31
Mounjaro	Tirzepatide	98	14
Ozempic	Semaglutide	98	21
Methylprednisolone	Methylprednisolone	97	83
Montelukast Sodium	Montelukast Sodium	88	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	27
Benazepril Hcl	Benazepril Hcl	80	21
Pioglitazone Hcl	Pioglitazone Hcl	80	26
Fluticasone Propionate	Fluticasone Propionate	75	38
Simvastatin	Simvastatin	67	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	67	23
Clonidine Hcl	Clonidine Hcl	66	21
Triamcinolone Acetonide	Triamcinolone Acetonide	65	39
Tamsulosin Hcl	Tamsulosin Hcl	64	21
Januvia	Sitagliptin Phosphate	60	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	21
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	57	41
Azithromycin	Azithromycin	56	52
Hydroxyzine Hcl	Hydroxyzine Hcl	53	24
Escitalopram Oxalate	Escitalopram Oxalate	52	14
Trazodone Hcl	Trazodone Hcl	52	22
Nifedipine Er	Nifedipine	51	16
Valacyclovir	Valacyclovir Hcl	50	15
Glipizide	Glipizide	41	15
Clopidogrel	Clopidogrel Bisulfate	40	17
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	16
Vitamin D2	Ergocalciferol (Vitamin D2)	40	14
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Chlorthalidone	Chlorthalidone	38	11
Atenolol	Atenolol	37	14
Spironolactone	Spironolactone	37	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	21
Eliquis	Apixaban	36	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	30
Cephalexin	Cephalexin	33	26
Lorazepam	Lorazepam	33	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Acyclovir	Acyclovir	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Ramipril	Ramipril	27	suppressed
Baclofen	Baclofen	26	15
Tradjenta	Linagliptin	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Fluconazole	Fluconazole	25	19
Synthroid	Levothyroxine Sodium	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Amoxicillin	Amoxicillin	24	22
Klor-Con M20	Potassium Chloride	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	17
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Linzess	Linaclotide	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	14
Terazosin Hcl	Terazosin Hcl	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	13
Azelastine Hcl	Azelastine Hcl	18	13
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Digoxin	Digoxin	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Methimazole	Methimazole	15	suppressed
Primidone	Primidone	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Valsartan	Valsartan	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nystatin	Nystatin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error